Posts
Chipotle stock sinks as restaurant chain reports falling traffic, weak guidance
2x MSFT Deep ITM Calls: 15JAN2027 $350
I don't know if you'd even call $350 "deep ITM" anymore, but bought this with MSFT around the upper $409 - lower $410 range today. Still concerned about possible sell offs or investor panic selling if MSFT shows any weakness. Comments welcome.
AMD Reports Fourth Quarter and Full Year 2025 Financial Results
SANTA CLARA, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the fourth quarter and full year of 2025. Fourth quarter revenue was a record $10.3 billion, gross margin was 54%, operating income was $1.8 billion, net income was $1.5 billion and diluted earnings per …
$AMD (Advanced Micro Devices) #earnings are out
Chipotle Mexican Grill Q4 Earnings Call Live Transcript
This post contains content not supported on old Reddit. [Click here to view the full post](https://sh.reddit.com/r/wallstreetbets/comments/1qv47vn)
Super Micro Computer Q2 Earnings Call Live Transcript
This post contains content not supported on old Reddit. [Click here to view the full post](https://sh.reddit.com/r/wallstreetbets/comments/1qv44py)
Advanced Micro Devices Q4 Earnings Call Live Transcript
This post contains content not supported on old Reddit. [Click here to view the full post](https://sh.reddit.com/r/wallstreetbets/comments/1qv40vf)
🇺🇸 US House passes government funding bill to end shutdown.
Multiple sources, including AP News and The New York Times, report that the US House passed a funding bill on February 3, 2026, to end the partial government shutdown, sending it to President Trump for signature. https://www.nytimes.com/live/2026/02/03/us/trump-news Sorry mod for not adding link before
Novo Nordisk -14% after forecasting a 5% to 13% sales drop in 2026 and a 14% Q4 profit decline
Source: [ https://finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html ](https://finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html) Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market. Eli Lilly was down about 4%, Structure Therapeutics fell 6.2%, while Altimmune dropped 4.2%. Viking Therapeutics declined more than …